(Q52426556)

English

Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemia.

scientific article published in August 1988

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

1 reference

based on heuristic

inferred from title

author name string

W G Peters

1

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

R Willemze

2

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

F E Zwaan

3

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

L P Colly

4

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

publication date

1 August 1988

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

57

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

2

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

91-95

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

Acute myeloid leukaemia: recent advances in therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Day 4 bone marrow aspirate for prediction of resistance to induction chemotherapy in acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of induction and consolidation treatment with intermediate and high-dose ara-C and m-AMSA containing regimens in patients with primarily failed or relapsed acute leukemia and non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cytosine arabinoside therapy for refractory leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3165680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00319732

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 May 2018

http://europepmc.org/abstract/MED/3165680

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52426556&oldid=1381480105"